LC
PFE icon

Lourd Capital’s Pfizer PFE Stock Holding History

Lourd Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.42M Buy
34,593
+1,033
+3% +$41K 0.13% 29
2019
Q1 		$1.35M Sell
33,560
-34,918
-51% -$1.4M 0.13% 26
2018
Q4 		$2.84M Buy
68,478
+946
+1% +$39.3K 0.22% 23
2018
Q3 		$2.82M Buy
67,532
+4,195
+7% +$161K 0.18% 23
2018
Q2 		$2.18M Sell
63,337
-597
-0.9% -$20.4K 0.31% 28
2018
Q1 		$2.15M Buy
63,934
+204
+0.3% +$7.01K 0.29% 32
2017
Q4 		$2.19M Buy
63,730
+33,615
+112% +$1.15M 0.14% 33
2017
Q3 		$1.02M Sell
30,115
-1,919
-6% -$61.7K 0.09% 37
2017
Q2 		$1.02M Buy
32,034
+730
+2% +$23K 0.1% 33
2017
Q1 		$1.02M Sell
31,304
-822
-3% -$25.9K 0.1% 31
2016
Q4 		$990K Sell
32,126
-177
-0.5% -$5.4K 0.1% 31
2016
Q3 		$1.04M Sell
32,303
-717
-2% -$24K 0.11% 31
2016
Q2 		$1.1M Buy
33,020
+581
+2% +$18.5K 0.31% 31
2016
Q1 		$912K Buy
32,439
+2,185
+7% +$62.4K 0.1% 39
2015
Q4 		$927K Buy
30,254
+2,607
+9% +$82K 0.1% 42
2015
Q3 		$824K Sell
27,647
-1,280
-4% -$41K 0.09% 42
2015
Q2 		$920K Buy
28,927
+466
+2% +$15.2K 0.09% 43
2015
Q1 		$939K Buy
28,461
+677
+2% +$21.5K 0.09% 42
2014
Q4 		$821K Buy
27,784
+463
+2% +$13.3K 0.08% 45
2014
Q3 		$766K Buy
27,321
+1,805
+7% +$50.7K 0.08% 47
2014
Q2 		$719K Buy
25,516
+179
+0.7% +$5.1K 0.08% 48
2014
Q1 		$772K Hold
25,337
– – 0.08% 46
2013
Q4 		$736K Hold
25,337
– – 0.08% 47
2013
Q3 		$691K Hold
25,337
– – 0.08% 47
2013
Q2 		$673K Buy
+25,337
New +$700K 0.08% 42

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lourd Capital's PFE Position: Q2 2019 in Review

Lourd Capital increased its Pfizer (PFE) stake by 3.1% in Q2 2019, buying an estimated $41K and bringing the position to 34,593 shares worth $1.42M. The position accounts for 0.13% of the portfolio, ranked #29.

Lourd Capital first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.84M in Q4 2018. 2,378 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Lourd Capital held 34,593 shares of Pfizer worth $1.42M as of Q2 2019.
  • Lourd Capital bought 1,033 Pfizer shares in Q2 2019, an estimated $41K.
  • Pfizer made up 0.13% of Lourd Capital's portfolio in Q2 2019, its #29 holding.
  • Lourd Capital first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • Lourd Capital's Pfizer position peaked at $2.84M in Q4 2018.
  • 2,378 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Lourd Capital's 13F filing for Q2 2019, filed 11 Jul 2019.